Loading...
The decision to use anticoagulation therapy must balance the reduced risk for thromboembolism against the increased risk for bleeding. The most feared complication -- intracranial hemorrhage -- weighs heavily in the decision. This case-control study identified risk factors for intracranial hemorrhage by comparing 121 patients who had intracranial hemorrhage while taking warfarin (77 intracerebral cases and 44 subdural) with 363 controls who received warfarin at a hospital anticoagulation clinic.
The main risk factor for intracerebral hemorrhage was the intensity of anticoagulation as measured by the prothrombin time ratio, or PTR (the patient's prothrombin time divided by the control value): with each 0.5 increase in PTR, the risk for intrac…